http://www.worldpress.org/Americas/2054.cfmAm Johal
Worldpress.org contributing editor
Vancouver, British Columbia
March 26, 2005
In February, Vancouver became the first city in North America to begin clinical trials for heroin prescription. This step, which required an exemption of Section 56 of the Controlled Drugs and Substances Act, came a year and a half after Vancouver had opened North America’s first safe injection site.
Dr. David Marsh, a clinical associate professor in the Department of Healthcare and Epidemiology at the University of British Columbia, says, “Each research subject will be on either heroin or another approved treatment substitute such as methadone.” According to him, Switzerland and the Netherlands have already approved regular treatment with heroin maintenance as part of the continuum of care after over 20,000 patient years of research. Marsh himself has worked for eight years in Canada to have the North American Opiate Medication Initiative (Naomi) study approved.
Writing in the Vancouver Sun, some addicts in the community have criticized parts of the study, which requires participants to give urine samples and reveal their medical histories and criminal records if they have one. They feel that there are too many barriers to enter the program and that it does not include enough participants.
The site is located in Vancouver’s Downtown Eastside neighborhood, in the downtown peninsula, not far from where the Olympic games will take place in 2010. It is near the existing health-board-managed safe injection site where users bring in their own drugs from the street. The purity of heroin available on the street has been an issue in the past and was deemed to be a contributing factor in many overdose deaths.
<snip>